Peripheral Drug Eluting Balloon Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
Description
Persistence Market Research has recently released a comprehensive report on the worldwide market for peripheral drug eluting balloons. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.
Key Insights:
Peripheral Drug Eluting Balloons Market Size (2025E): USD 1035.2 Million
Projected Market Value (2032F): USD 1,844.3 Million
Global Market Growth Rate (CAGR 2025 to 2032): 8.6%
Peripheral Drug Eluting Balloons Market – Report Scope:
Peripheral drug eluting balloons are specialized angioplasty devices used primarily in the treatment of peripheral artery disease (PAD), which affects blood flow in limbs. These balloons are coated with anti-proliferative drugs such as paclitaxel or sirolimus, which are released during the procedure to prevent restenosis or the re-narrowing of the arteries. The peripheral drug eluting balloons market caters to hospitals, specialty vascular centers, ambulatory surgical units, and catheterization labs, offering an effective, minimally invasive alternative to traditional stents. Market growth is driven by the increasing global burden of PAD, rising demand for advanced interventional cardiology devices, and continued advancements in balloon and drug coating technologies, enhancing treatment outcomes and reducing the need for repeat procedures.
Market Growth Drivers:
The global peripheral drug eluting balloons market is propelled by several key factors, including the rising prevalence of diabetes, hypertension, obesity, and smoking — all major risk factors for PAD. Increased awareness and diagnosis of vascular diseases are leading to greater demand for safe and efficient treatments. Technological advancements, such as improved balloon design, drug delivery mechanisms, and newer formulations of anti-restenotic agents, are enhancing the efficacy of drug eluting balloons. Additionally, a growing shift toward minimally invasive procedures, along with favorable reimbursement policies in developed regions and increasing healthcare investments in emerging markets, are significantly contributing to market expansion.
Market Restraints:
Despite promising growth prospects, the peripheral drug eluting balloons market faces challenges related to regulatory scrutiny, especially concerning safety data for paclitaxel-coated devices following recent clinical debates. These concerns have led to cautious adoption in some healthcare settings and stricter oversight from regulatory agencies. Additionally, the high cost of drug eluting balloon procedures, combined with limited reimbursement coverage in certain countries, poses a barrier to widespread market penetration. Competitive alternatives, such as drug-eluting stents and plain balloon angioplasty, further impact market adoption, particularly in price-sensitive regions.
Market Opportunities:
The peripheral drug eluting balloons market presents significant growth opportunities driven by innovations in drug coating technologies, the development of biodegradable balloon platforms, and expanding applications in smaller vessels and below-the-knee lesions. Emerging markets in Asia Pacific and Latin America are expected to offer substantial potential due to growing healthcare infrastructure, increased prevalence of PAD, and improved access to interventional treatments. Strategic partnerships between manufacturers and healthcare providers, alongside investments in clinical trials to validate long-term safety and efficacy, are likely to create new pathways for product approvals and market expansion. Digital health integration and real-time imaging technologies also present new frontiers for innovation and patient-centric care delivery.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the peripheral drug eluting balloons market globally?
Which drug types and applications are driving adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the peripheral drug eluting balloons market?
Who are the key players contributing to the peripheral drug eluting balloons market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global peripheral drug eluting balloons market?
Competitive Intelligence and Business Strategy:
These companies are actively investing in research and development to introduce next-generation DEBs with improved biocompatibility and more precise drug delivery. Collaborations with regulatory agencies and healthcare providers enable accelerated approvals and market entry in diverse regions. Additionally, efforts to expand distribution networks and offer training and support to clinicians play a crucial role in enhancing adoption and end-user confidence. Other key players are also prioritizing geographic expansion, particularly in underserved markets, through acquisitions, partnerships, and localized manufacturing strategies.
Key Companies Profiled:
Abbott Laboratories
Boston Scientific Corporation
Cook Medical Inc.
MicroPort Scientific Corporation (Endovastec™)
Medtronic Plc.
Cardinal Health, Inc.
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
W. L. Gore & Associates Inc.
Getinge AB
Terumo Corp
Kyoto Medical Planning Co Ltd
iVascular S.L.U
AMG International GmbH
ENDOCOR GmbH
Meril Life Sciences Pvt. Ltd.
Nano Therapeutics Pvt Ltd
Koninklijke Philips N.V.
REVA Medical
Peripheral Drug Eluting Balloons Market Research Segmentation:
Drug Coating:
Paclitaxel Drug Coating
Sirolimus drug Coating
Others
Indication:
Peripheral Arterial Disease
Peripheral Aneurysms
In-Stent Restenosis
Others
Artery Type:
Carotid Arteries
Fem-Pop Arteries
Iliac Arteries
Infrapop Arteries
End User:
Hospitals
Ambulatory Surgical Centers/Outpatients
Cardiac Catheterization Labs
Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Insights:
Peripheral Drug Eluting Balloons Market Size (2025E): USD 1035.2 Million
Projected Market Value (2032F): USD 1,844.3 Million
Global Market Growth Rate (CAGR 2025 to 2032): 8.6%
Peripheral Drug Eluting Balloons Market – Report Scope:
Peripheral drug eluting balloons are specialized angioplasty devices used primarily in the treatment of peripheral artery disease (PAD), which affects blood flow in limbs. These balloons are coated with anti-proliferative drugs such as paclitaxel or sirolimus, which are released during the procedure to prevent restenosis or the re-narrowing of the arteries. The peripheral drug eluting balloons market caters to hospitals, specialty vascular centers, ambulatory surgical units, and catheterization labs, offering an effective, minimally invasive alternative to traditional stents. Market growth is driven by the increasing global burden of PAD, rising demand for advanced interventional cardiology devices, and continued advancements in balloon and drug coating technologies, enhancing treatment outcomes and reducing the need for repeat procedures.
Market Growth Drivers:
The global peripheral drug eluting balloons market is propelled by several key factors, including the rising prevalence of diabetes, hypertension, obesity, and smoking — all major risk factors for PAD. Increased awareness and diagnosis of vascular diseases are leading to greater demand for safe and efficient treatments. Technological advancements, such as improved balloon design, drug delivery mechanisms, and newer formulations of anti-restenotic agents, are enhancing the efficacy of drug eluting balloons. Additionally, a growing shift toward minimally invasive procedures, along with favorable reimbursement policies in developed regions and increasing healthcare investments in emerging markets, are significantly contributing to market expansion.
Market Restraints:
Despite promising growth prospects, the peripheral drug eluting balloons market faces challenges related to regulatory scrutiny, especially concerning safety data for paclitaxel-coated devices following recent clinical debates. These concerns have led to cautious adoption in some healthcare settings and stricter oversight from regulatory agencies. Additionally, the high cost of drug eluting balloon procedures, combined with limited reimbursement coverage in certain countries, poses a barrier to widespread market penetration. Competitive alternatives, such as drug-eluting stents and plain balloon angioplasty, further impact market adoption, particularly in price-sensitive regions.
Market Opportunities:
The peripheral drug eluting balloons market presents significant growth opportunities driven by innovations in drug coating technologies, the development of biodegradable balloon platforms, and expanding applications in smaller vessels and below-the-knee lesions. Emerging markets in Asia Pacific and Latin America are expected to offer substantial potential due to growing healthcare infrastructure, increased prevalence of PAD, and improved access to interventional treatments. Strategic partnerships between manufacturers and healthcare providers, alongside investments in clinical trials to validate long-term safety and efficacy, are likely to create new pathways for product approvals and market expansion. Digital health integration and real-time imaging technologies also present new frontiers for innovation and patient-centric care delivery.
Key Questions Answered in the Report:
What are the primary factors driving the growth of the peripheral drug eluting balloons market globally?
Which drug types and applications are driving adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the peripheral drug eluting balloons market?
Who are the key players contributing to the peripheral drug eluting balloons market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global peripheral drug eluting balloons market?
Competitive Intelligence and Business Strategy:
These companies are actively investing in research and development to introduce next-generation DEBs with improved biocompatibility and more precise drug delivery. Collaborations with regulatory agencies and healthcare providers enable accelerated approvals and market entry in diverse regions. Additionally, efforts to expand distribution networks and offer training and support to clinicians play a crucial role in enhancing adoption and end-user confidence. Other key players are also prioritizing geographic expansion, particularly in underserved markets, through acquisitions, partnerships, and localized manufacturing strategies.
Key Companies Profiled:
Abbott Laboratories
Boston Scientific Corporation
Cook Medical Inc.
MicroPort Scientific Corporation (Endovastec™)
Medtronic Plc.
Cardinal Health, Inc.
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Becton, Dickinson and Company
W. L. Gore & Associates Inc.
Getinge AB
Terumo Corp
Kyoto Medical Planning Co Ltd
iVascular S.L.U
AMG International GmbH
ENDOCOR GmbH
Meril Life Sciences Pvt. Ltd.
Nano Therapeutics Pvt Ltd
Koninklijke Philips N.V.
REVA Medical
Peripheral Drug Eluting Balloons Market Research Segmentation:
Drug Coating:
Paclitaxel Drug Coating
Sirolimus drug Coating
Others
Indication:
Peripheral Arterial Disease
Peripheral Aneurysms
In-Stent Restenosis
Others
Artery Type:
Carotid Arteries
Fem-Pop Arteries
Iliac Arteries
Infrapop Arteries
End User:
Hospitals
Ambulatory Surgical Centers/Outpatients
Cardiac Catheterization Labs
Region:
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Table of Contents
273 Pages
- 1. Executive Summary
- 1.1. Global Peripheral Drug Eluting Balloons Market Snapshot 2025 and 2032
- 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
- 1.3. Key Market Trends
- 1.4. Industry Developments and Key Market Events
- 1.5. Demand Side and Supply Side Analysis
- 1.6. PMR Analysis and Recommendations
- 2. Market Overview
- 2.1. Market Scope and Definitions
- 2.2. Value Chain Analysis
- 2.3. Macro-Economic Factors
- 2.3.1. Global GDP Outlook
- 2.3.2. Global Construction Industry Overview
- 2.3.3. Global Mining Industry Overview
- 2.4. Forecast Factors – Relevance and Impact
- 2.5. COVID-19 Impact Assessment
- 2.6. PESTLE Analysis
- 2.7. Porter's Five Forces Analysis
- 2.8. Geopolitical Tensions: Market Impact
- 2.9. Regulatory and Technology Landscape
- 3. Market Dynamics
- 3.1. Drivers
- 3.2. Restraints
- 3.3. Opportunities
- 3.4. Trends
- 4. Price Trend Analysis, 2019-2032
- 4.1. Region-wise Price Analysis
- 4.2. Price by Segments
- 4.3. Price Impact Factors
- 5. Global Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 5.1. Key Highlights
- 5.2. Global Peripheral Drug Eluting Balloons Market Outlook: Drug Coating
- 5.2.1. Introduction/Key Findings
- 5.2.2. Historical Market Size (US$ Mn) Analysis by Drug Coating, 2019-2024
- 5.2.3. Current Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
- 5.2.3.1. Paclitaxel Drug Coating
- 5.2.3.2. Sirolimus drug Coating
- 5.2.4. Market Attractiveness Analysis: Drug Coating
- 5.3. Global Peripheral Drug Eluting Balloons Market Outlook: Indication
- 5.3.1. Introduction/Key Findings
- 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 5.3.3.1. Peripheral Arterial Disease
- 5.3.3.2. Peripheral Aneurysms
- 5.3.3.3. In-Stent Restenosis
- 5.3.4. Market Attractiveness Analysis: Indication
- 5.4. Global Peripheral Drug Eluting Balloons Market Outlook: Artery Type
- 5.4.1. Introduction/Key Findings
- 5.4.2. Historical Market Size (US$ Mn) Analysis by Artery Type, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
- 5.4.3.1. Carotid Arteries
- 5.4.3.2. Fem-Pop Arteries
- 5.4.3.3. Iliac Arteries
- 5.4.3.4. Infrapop Arteries
- 5.4.4. Market Attractiveness Analysis: Artery Type
- 5.5. Global Peripheral Drug Eluting Balloons Market Outlook: End User
- 5.5.1. Introduction/Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
- 5.5.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 5.5.3.1. Hospitals
- 5.5.3.2. Ambulatory Surgical Centers/Outpatients
- 5.5.3.3. Cardiac Catheterization Labs
- 5.5.4. Market Attractiveness Analysis: End User
- 6. Global Peripheral Drug Eluting Balloons Market Outlook: Region
- 6.1. Key Highlights
- 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
- 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia & Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
- 6.4. Market Attractiveness Analysis: Region
- 7. North America Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 7.1. Key Highlights
- 7.2. Pricing Analysis
- 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
- 7.4. North America Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
- 7.4.1. Paclitaxel Drug Coating
- 7.4.2. Sirolimus drug Coating
- 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 7.5.1. Peripheral Arterial Disease
- 7.5.2. Peripheral Aneurysms
- 7.5.3. In-Stent Restenosis
- 7.6. North America Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
- 7.6.1. Carotid Arteries
- 7.6.2. Fem-Pop Arteries
- 7.6.3. Iliac Arteries
- 7.6.4. Infrapop Arteries
- 7.7. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 7.7.1. Hospitals
- 7.7.2. Ambulatory Surgical Centers/Outpatients
- 7.7.3. Cardiac Catheterization Labs
- 8. Europe Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 8.1. Key Highlights
- 8.2. Pricing Analysis
- 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. Italy
- 8.3.3. France
- 8.3.4. U.K.
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Rest of Europe
- 8.4. Europe Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
- 8.4.1. Paclitaxel Drug Coating
- 8.4.2. Sirolimus drug Coating
- 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 8.5.1. Peripheral Arterial Disease
- 8.5.2. Peripheral Aneurysms
- 8.5.3. In-Stent Restenosis
- 8.6. Europe Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
- 8.6.1. Carotid Arteries
- 8.6.2. Fem-Pop Arteries
- 8.6.3. Iliac Arteries
- 8.6.4. Infrapop Arteries
- 8.7. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 8.7.1. Hospitals
- 8.7.2. Ambulatory Surgical Centers/Outpatients
- 8.7.3. Cardiac Catheterization Labs
- 9. East Asia Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 9.1. Key Highlights
- 9.2. Pricing Analysis
- 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
- 9.4. East Asia Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
- 9.4.1. Paclitaxel Drug Coating
- 9.4.2. Sirolimus drug Coating
- 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 9.5.1. Peripheral Arterial Disease
- 9.5.2. Peripheral Aneurysms
- 9.5.3. In-Stent Restenosis
- 9.6. East Asia Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
- 9.6.1. Carotid Arteries
- 9.6.2. Fem-Pop Arteries
- 9.6.3. Iliac Arteries
- 9.6.4. Infrapop Arteries
- 9.7. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 9.7.1. Hospitals
- 9.7.2. Ambulatory Surgical Centers/Outpatients
- 9.7.3. Cardiac Catheterization Labs
- 10. South Asia & Oceania Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 10.1. Key Highlights
- 10.2. Pricing Analysis
- 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of SAO
- 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
- 10.4.1. Paclitaxel Drug Coating
- 10.4.2. Sirolimus drug Coating
- 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 10.5.1. Peripheral Arterial Disease
- 10.5.2. Peripheral Aneurysms
- 10.5.3. In-Stent Restenosis
- 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
- 10.6.1. Carotid Arteries
- 10.6.2. Fem-Pop Arteries
- 10.6.3. Iliac Arteries
- 10.6.4. Infrapop Arteries
- 10.7. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 10.7.1. Hospitals
- 10.7.2. Ambulatory Surgical Centers/Outpatients
- 10.7.3. Cardiac Catheterization Labs
- 11. Latin America Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 11.1. Key Highlights
- 11.2. Pricing Analysis
- 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of LATAM
- 11.4. Latin America Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
- 11.4.1. Paclitaxel Drug Coating
- 11.4.2. Sirolimus drug Coating
- 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 11.5.1. Peripheral Arterial Disease
- 11.5.2. Peripheral Aneurysms
- 11.5.3. In-Stent Restenosis
- 11.6. Latin America Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
- 11.6.1. Carotid Arteries
- 11.6.2. Fem-Pop Arteries
- 11.6.3. Iliac Arteries
- 11.6.4. Infrapop Arteries
- 11.7. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 11.7.1. Hospitals
- 11.7.2. Ambulatory Surgical Centers/Outpatients
- 11.7.3. Cardiac Catheterization Labs
- 12. Middle East & Africa Peripheral Drug Eluting Balloons Market Outlook: Historical (2019-2024) and Forecast (2025-2032)
- 12.1. Key Highlights
- 12.2. Pricing Analysis
- 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. South Africa
- 12.3.3. Northern Africa
- 12.3.4. Rest of MEA
- 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Drug Coating, 2025-2032
- 12.4.1. Paclitaxel Drug Coating
- 12.4.2. Sirolimus drug Coating
- 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
- 12.5.1. Peripheral Arterial Disease
- 12.5.2. Peripheral Aneurysms
- 12.5.3. In-Stent Restenosis
- 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by Artery Type, 2025-2032
- 12.6.1. Carotid Arteries
- 12.6.2. Fem-Pop Arteries
- 12.6.3. Iliac Arteries
- 12.6.4. Infrapop Arteries
- 12.7. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
- 12.7.1. Hospitals
- 12.7.2. Ambulatory Surgical Centers/Outpatients
- 12.7.3. Cardiac Catheterization Labs
- 13. Competition Landscape
- 13.1. Market Share Analysis, 2025
- 13.2. Market Structure
- 13.2.1. Competition Intensity Mapping
- 13.2.2. Competition Dashboard
- 13.3. Company Profiles
- 13.3.1. Abbott Laboratories
- 13.3.1.1. Company Overview
- 13.3.1.2. Product Portfolio/Offerings
- 13.3.1.3. Key Financials
- 13.3.1.4. SWOT Analysis
- 13.3.1.5. Company Strategy and Key Developments
- 13.3.2. Boston Scientific Corporation
- 13.3.3. Cook Medical Inc.
- 13.3.4. MicroPort Scientific Corporation (Endovastec™)
- 13.3.5. Medtronic Plc.
- 13.3.6. Cardinal Health, Inc.
- 13.3.7. B. Braun Melsungen AG
- 13.3.8. BIOTRONIK SE & Co. KG
- 13.3.9. Becton, Dickinson and Company
- 13.3.10. W. L. Gore & Associates Inc.
- 13.3.11. Getinge AB
- 13.3.12. Terumo Corp
- 13.3.13. Kyoto Medical Planning Co Ltd
- 13.3.14. iVascular S.L.U
- 13.3.15. AMG International GmbH
- 14. Appendix
- 14.1. Research Methodology
- 14.2. Research Assumptions
- 14.3. Acronyms and Abbreviations
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
